Selected article for: "acute ARDS respiratory distress syndrome and critical illness"
Author: Post, Adrian; Bakker, Stephan J.L.; Dullaart, Robin P.F.
Title: Obesity, adipokines and COVID‐19
  • Cord-id: 8jtnhgnj
  • Document date: 2020_6_12
    • ID: 8jtnhgnj
    Snippet: The SARS‐CoV‐2 pandemic has led to worldwide research aiming to identify the risk factors for developing critical illness and mortality caused by COVID‐19. It quickly became apparent that besides older age, obesity is one of the most important risk factors for a more severe course of COVID‐19, although the mechanisms remain largely unknown [1‐3]. Notably, with respect to acute respiratory distress syndrome (ARDS) and acute lung injury (ALI), evidence is mounting that obesity is a risk
    Document: The SARS‐CoV‐2 pandemic has led to worldwide research aiming to identify the risk factors for developing critical illness and mortality caused by COVID‐19. It quickly became apparent that besides older age, obesity is one of the most important risk factors for a more severe course of COVID‐19, although the mechanisms remain largely unknown [1‐3]. Notably, with respect to acute respiratory distress syndrome (ARDS) and acute lung injury (ALI), evidence is mounting that obesity is a risk factor for ARDS/ALI, but among people with ARDS/ALI, obesity is associated with better outcome, a phenomenon which has been called the “obesity paradox” [4,5].

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adipose tissue: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and adipose tissue dysfunction: 1, 2
    • acute ards respiratory distress syndrome and low grade chronic inflammation: 1
    • acute ards respiratory distress syndrome and low grade chronic inflammation state: 1
    • acute lung injury and adaptive immune response: 1, 2, 3, 4, 5
    • acute lung injury and adipose tissue: 1, 2
    • adaptive immune response and adipose tissue: 1, 2, 3
    • adaptive immune response and low grade chronic inflammation: 1
    • adaptive immune response and low grade chronic inflammation state: 1
    • adipose tissue and low grade chronic inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • adipose tissue and low grade chronic inflammation state: 1, 2
    • adipose tissue dysfunction and low grade chronic inflammation: 1